Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results90% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (6)
Early P 1 (1)
P 1 (19)
P 2 (4)
P 4 (1)

Trial Status

Unknown22
Completed9
Recruiting3
Not Yet Recruiting1
Active Not Recruiting1
Terminated1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT05095532Phase 1Recruiting

Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT

NCT05522569Unknown

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

NCT07519031Phase 1Not Yet Recruiting

Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo

NCT06077734Terminated

Muscle Stem Cell Quality in Atrophy

NCT04356287Phase 1Recruiting

Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis

NCT03478215Phase 2Active Not Recruiting

Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

NCT04014166Not ApplicableCompleted

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

NCT06610773Phase 1Recruiting

HUC-MSC for Treatment of High-risk HPV Infection

NCT06360861Phase 1Completed

Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis

NCT06149832Phase 4UnknownPrimary

Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing

NCT05274295Not ApplicableUnknown

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Diabetic Leg Ulcers

NCT05165459Not ApplicableUnknown

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers

NCT04194671Phase 1Unknown

Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury

NCT05018754Completed

Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF

NCT04863183Phase 1UnknownPrimary

Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis

NCT04125329Early Phase 1UnknownPrimary

Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy

NCT02302599Phase 2Completed

Mesenchymal Stem Cells to Treat Type 2 Diabetes

NCT03874572Phase 1Unknown

Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth

NCT03876197Phase 1Unknown

Mesenchymal Stem Cells for Radiation-induced Xerostomia

NCT04441658Phase 1Unknown

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus

Scroll to load more

Research Network

Activity Timeline